Brazil begins debate on pharmaceutical production of Cannabis

Anvisa has initiated a discussion on the regulation of the cultivation of Cannabis for medicinal purposes in Brazil, a move that promises to transform the national pharmaceutical industry and open new opportunities for scientific, technological, and economic advancements. The measure has the potential to make the country more autonomous in the production of Cannabis-based medications, reduce costs, attract investments, and stimulate employment in the sector. Experts point out that the practical experience of Brazilian companies in countries with established regulatory frameworks, such as Colombia, can serve as a reference for the development of a structured production chain in Brazil. The goal is to ensure standardization and traceability in the cultivation with a pharmaceutical focus, strengthening national production and creating a conducive environment for research, technological innovation, and scientific development. “The regulation of the medicinal cultivation of Cannabis ...